T-cell immunity to the folate receptor alpha is prevalent in women with breast or ovarian cancer. (Q51935197)
Jump to navigation
Jump to search
scientific article published on 14 August 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | T-cell immunity to the folate receptor alpha is prevalent in women with breast or ovarian cancer. |
scientific article published on 14 August 2006 |
Statements
T-cell immunity to the folate receptor alpha is prevalent in women with breast or ovarian cancer. (English)
1 reference
1 reference
Linda E Kelemen
1 reference
Lynn C Hartmann
1 reference
Kimberly R Kalli
1 reference
Keith L Knutson
1 reference
Karin Goodman
1 reference
Courtney L Erskine
1 reference
Christopher J Krco
1 reference
Peter J Wettstein
1 reference
14 August 2006
1 reference
24
1 reference
26
1 reference
4254-4261
1 reference